Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks

被引：0
作者：
Longhurst, Hilary [1 ]
Aberer, Werner [2 ]
Bouillet, Laurence [3 ]
Caballero, Teresa [4 ]
Fabien, Vincent [5 ]
Kanny, Gisele [6 ]
Zanichelli, Andrea [7 ]
Maurer, Marcus [8 ]
机构：
[1] Barts & London Hosp, London, England
[2] Med Univ Graz, Graz, Austria
[3] Grenoble Univ Hosp, Grenoble, France
[4] Hosp La Paz Res Ctr IdiPaz, Madrid, Spain
[5] Shire Human Genet Therapies, Eysins, Switzerland
[6] Univ Lorraine, Vandoeuvre Les Nancy, France
[7] Luigi Sacco Univ Milan, Milan, Italy
[8] Charite, D-13353 Berlin, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.798
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB33 / AB33
页数：1
相关论文
共 50 条
  • [21] Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey
    Andresen, Irmgard
    Longhurst, Hilary
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Grumach, Anete S.
    Maurer, Marcus
    Botha, Jaco
    Zanichelli, Andrea
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB44 - AB44
  • [22] EARLY ICATIBANT TREATMENT IS ASSOCIATED WITH FASTER RESOLUTION OF HEREDITARY ANGIOEDEMA ATTACKS: REAL-WORLD DATA FROM THE ICATIBANT OUTCOME SURVEY
    Longhurst, H.
    Caballero, T.
    Zanichelli, A.
    Aberer, W.
    Fabien, V.
    Bouillet, L.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A47 - A48
  • [23] Self-administration of icatibant to treat hereditary angioedema in four patients with moderate to severe attacks
    Abajian, M.
    Doumoulakis, G.
    Agnieszka, M.
    Schoepke, N.
    Maurer, M.
    Magerl, M.
    ALLERGY, 2012, 67 : 353 - 353
  • [24] ICATIBANT FOR HEREDITARY ANGIOEDEMA
    Gras, Jordi
    DRUGS OF TODAY, 2009, 45 (12) : 855 - 864
  • [25] A study of the safety, tolerability and efficacy of self-administration of icatibant for acute attacks of hereditary angioedema
    Aberer, W.
    Wiednig, M.
    Reshef, A.
    Nair, N.
    Lachmann, A.
    Hoch, B.
    Bloom, B.
    Longhurst, H.
    Maurer, M.
    Kivity, S.
    Malbran, A.
    ALLERGY, 2011, 66 : 80 - 80
  • [26] Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
    Yang W.
    Hébert J.
    Ritchie B.
    Baptista J.
    Riedl M.
    Lumry W.R.
    Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
  • [27] Audit of the treatment of attacks of hereditary angioedema with icatibant in two United Kingdom immunology departments
    Bright, P.
    Longhurst, H.
    Dempster, J.
    ALLERGY, 2011, 66 : 430 - 431
  • [28] Treatment of Hereditary Angioedema Attacks with Icatibant: A Comparison of Observational Data with Clinical Trial Data
    Maurer, Marcus
    Longhurst, Hilary
    Li, Huamin Henry
    Fabien, Vincent
    Lumry, William R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB32 - AB32
  • [29] Management of acute attacks of hereditary angioedema: potential role of icatibant
    Longhurst, Hilary J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 795 - 802
  • [30] REINJECTION OF ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS: RESULTS FROM AN ANALYSIS OF MORE THAN 2000 ATTACKS
    Andresen, I.
    Longhurst, H. J.
    Aberer, W.
    Bouillet, L.
    Caballero, T.
    Fabien, V.
    Zanichelli, A.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A114 - A115
12345